Milson Yu

Partner
Full contact info

About Milson

Milson represents private and public companies and investment banks in various capital markets and corporate transactions, including initial public offerings, follow-on and secondary offerings, debt offerings and SPAC mergers. Milson also counsels public companies on a full range of corporate and securities matters, including SEC reporting obligations and corporate governance.

Milson’s recent representative transactions include advising:

  • Instacart on its $660 million IPO
  • Confluent on its $828 million IPO and its $1.1 billion Rule 144A convertible notes offering
  • 1Life Healthcare (One Medical) on its:
    • $281.8 million IPO
    • $275 million Rule 144A convertible notes offering
    • $2.1 billion all-stock acquisition of Iora Health
  • Thayer Ventures on its $1.1 billion deSPAC business combination with Inspirato
  • Opthea on its $128 million IPO
  • Docebo on its $165.6 million IPO and multiple secondary offerings
  • Absolute Software on its $69 million IPO and its $340 million cash acquisition of NetMotion
  • The underwriters on AssetMark’s $316 million IPO
  • NVIDIA on registered notes offerings raising $10 billion in aggregate
  • Jazz Pharmaceuticals on its $1 billion Rule 144A exchangeable notes offering

Education

Cornell Law School
JD, 2013, cum laude

Samuel Curtis Johnson Graduate School of Management, Cornell University
MBA, 2013, with distinction

Georgia Institute of Technology
BSM, 2010, magna cum laude

Rankings and accolades

Chambers USA: Capital Markets: Debt & Equity: Western United States – Nationwide (2024)

Chambers USA: Up and Coming for Capital Markets: Debt & Equity – California (2024)

Law360: Rising Stars of 2024